Literature DB >> 21698703

MRI assessment of iron deposition in multiple sclerosis.

Stefan Ropele1, Wolter de Graaf, Michael Khalil, Mike P Wattjes, Christian Langkammer, Maria A Rocca, Alex Rovira, Jacqueline Palace, Frederik Barkhof, Massimo Filippi, Franz Fazekas.   

Abstract

Iron deposition in the human brain tissue occurs in the process of normal aging and in many neurodegenerative diseases. Elevated iron levels in certain brain regions are also an increasingly recognized finding in multiple sclerosis (MS). The exact mechanism(s) for this phenomenon and its implication in terms of pathophysiology and clinical significance are still largely unknown and debated. Reliable methods to exactly quantify brain iron are a first step to clarify these issues. Therefore, the aim of this review is to present currently available magnetic resonance imaging (MRI) techniques for the assessment of brain iron. These include relaxation time mapping, phase imaging, susceptibility-weighted imaging, susceptibility mapping, magnetic field correlation imaging, and direct saturation imaging. After discussing their advantages and disadvantages, existing MRI clinical correlations with brain iron concentration in MS are summarized and future research directions are shown.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698703     DOI: 10.1002/jmri.22590

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  32 in total

1.  Susceptibility-weighted imaging in patients with pyogenic brain abscesses at 1.5T: characteristics of the abscess capsule.

Authors:  P H Lai; H C Chang; T C Chuang; H W Chung; J Y Li; M J Weng; J H Fu; P C Wang; S C Li; H B Pan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-26       Impact factor: 3.825

Review 2.  CCSVI and MS: no meaning, no fact.

Authors:  Claudio Baracchini; Matteo Atzori; Paolo Gallo
Journal:  Neurol Sci       Date:  2012-05-09       Impact factor: 3.307

Review 3.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

4.  Assessment of Iron Deposition in the Brain in Frontotemporal Dementia and Its Correlation with Behavioral Traits.

Authors:  R Sheelakumari; C Kesavadas; T Varghese; R M Sreedharan; B Thomas; J Verghese; P S Mathuranath
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-24       Impact factor: 3.825

Review 5.  Identification of mineral deposits in the brain on radiological images: a systematic review.

Authors:  Maria del C Valdés Hernández; Lucy C Maconick; Elizabeth M J Tan; Joanna M Wardlaw
Journal:  Eur Radiol       Date:  2012-06-12       Impact factor: 5.315

6.  Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.

Authors:  Wolter L de Graaf; Iris D Kilsdonk; Alexandra Lopez-Soriano; Jaco J M Zwanenburg; Fredy Visser; Chris H Polman; Jonas A Castelijns; Jeroen J G Geurts; Petra J W Pouwels; Peter R Luijten; Frederik Barkhof; Mike P Wattjes
Journal:  Eur Radiol       Date:  2012-08-17       Impact factor: 5.315

7.  Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.

Authors:  Iris D Kilsdonk; Mike P Wattjes; Alexandra Lopez-Soriano; Joost P A Kuijer; Marcus C de Jong; Wolter L de Graaf; Mandy M A Conijn; Chris H Polman; Peter R Luijten; Jeroen J G Geurts; Mirjam I Geerlings; Frederik Barkhof
Journal:  Eur Radiol       Date:  2013-12-09       Impact factor: 5.315

8.  Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics.

Authors:  Iris D Kilsdonk; Alexandra Lopez-Soriano; Joost P A Kuijer; Wolter L de Graaf; Jonas A Castelijns; Chris H Polman; Peter R Luijten; Jeroen J J G Geurts; Frederik Barkhof; Mike P Wattjes
Journal:  J Neurol       Date:  2014-04-29       Impact factor: 4.849

Review 9.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

10.  Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.

Authors:  Y Zhang; S A Gauthier; A Gupta; L Tu; J Comunale; G C-Y Chiang; W Chen; C A Salustri; W Zhu; Y Wang
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.